SEMA7A and non-small cell lung carcinoma: In this study, by using bioinformatics analysis and an established Lewis lung carcinoma mouse model, we found that SEMA7A was upregulated in the patients with NSCLC and was positively correlated with the tumor progression and poor prognosis.